Browse medicines, page 7 of 9
Some records contain detailed evidence; others currently contain only basic identity and regulatory information. Reviewed conclusions appear only when they are available for a specific use and group of people.
Showing 361–420 of 526 records
Tick-Borne Encephalitis Purified Antigen (Ticovac)
Protein medicineLaboratory or animal-stage researchExpanded recordTyrosinase
Protein medicineDietary supplement; not FDA-approved as a medicineExpanded recordUstekinumab-Srlf (Imuldosa)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who are candidates for phototherapy or syste
Xylanase
Protein medicineDietary supplement; not FDA-approved as a medicineExpanded recordYellowfin Tuna (Tuna)
Protein medicineLaboratory or animal-stage researchExpanded recordZolbetuximab-Clzb (Vyloy)
Protein medicineApproved in the United States (FDA)Expanded recordChloramphenicol (Chloromycetin / Chloramphenicol Sodium Succinate / Econochlor / Chlorofair / Mychel-S / Mychel)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Temporarily relieves discomfort due to kidney issues, including occasional frequent urination, foamy urine, headaches, increased blood pressure levels, increased tiredness, itching, lower back discomfort, nausea, loss of appetite, vomiting, need to urinate at night, muscle twitching, and cramps.* *CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE, NOT FDA EVALUATED. This product is not intended to diagnose, treat, cure, or prevent any disease.
Desoxyribonuclease (Elase-Chloromycetin)
Protein medicineApproved in the United States (FDA)Expanded recordDornase alfa (Pulmozyme)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Cystic fibrosis (CF) to improve pulmonary function
Human Serum Albumin I-131 (Megatope / Volumex)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Determinations of total blood and plasma volumes and in protein turnover studies
Letibotulinumtoxina (Letybo)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
The temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity
Lonapegsomatropin-Tcgd (Skytrofa)
Protein medicineApproved in the United States (FDA)Expanded recordLoncastuximab Tesirine (Zynlonta)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell
Mecasermin Rinfabate Recombinant (Iplex)
Protein medicineApproved in the United States (FDA)Expanded recordMethoxy Polyethylene Glycol-Epoetin beta (Mircera)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Anemia associated with chronic kidney disease
Mirikizumab-Mrkz (Omvoh)
Protein medicineApproved in the United States (FDA)Expanded recordMosunetuzumab-Axgb (Lunsumio Velo / Lunsumio)
Protein medicineApproved in the United States (FDA)Expanded recordNatalizumab-Sztn (Tyruko)
Protein medicineApproved in the United States (FDA)Expanded recordNaxitamab-Gqgk (Danyelza)
Protein medicineApproved in the United States (FDA)Expanded recordNorthern Brown Shrimp (Shrimp)
Protein medicineLaboratory or animal-stage researchExpanded recordOcriplasmin (Jetrea)
Protein medicineApproved in the United States (FDA)Expanded recordOlipudase Alfa-Rpcp (Xenpozyme)
Protein medicineApproved in the United States (FDA)Expanded recordPancrelipase (Zenpep / Pancreaze / Creon / Pertzye / Viokace / Cotazym)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
HOMEOPATHIC INDICATIONS: For the temporary relief of symptoms related to leaky gut syndrome such as fatigue, seasonal allergies, joint pain, occasional constipation, mental fogginess and occasional diarrhea.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.
Pegfilgrastim-Cbqv (Udenyca)
Protein medicineApproved in the United States (FDA)Expanded recordPegvaliase (Palynziq)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Blood phenylalanine concentrations
Pegvaliase-Pqpz (Palynziq)
Protein medicineApproved in the United States (FDA)Expanded recordPoliovirus Type 2 Antigen (Ipol / Pediarix / Quadracel / Kinrix / Vaxelis)
Protein medicineLaboratory or animal-stage researchExpanded recordPolistes Spp. Venom Protein (Wasp Hymenoptera Venom Multidose)
Protein medicineLaboratory or animal-stage researchExpanded recordPoultry, Unspecified (Food - Animal Products and Poultry Products, Chicken Meat Gallus Sp.)
Protein medicineLaboratory or animal-stage researchExpanded recordPullulanase
Protein medicineDietary supplement; not FDA-approved as a medicineExpanded recordRozanolixizumab-Noli (Rystiggo)
Protein medicineApproved in the United States (FDA)Expanded recordSacituzumab Govitecan (Trodelvy)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Unresectable locally advanced or mTNBC who have received two or more prior systemic therapies, at least one of them
Somapacitan-Beco (Sogroya)
Protein medicineApproved in the United States (FDA)Expanded recordSomatrogon-Ghla (Ngenla)
Protein medicineApproved in the United States (FDA)Expanded recordStreptococcus Pneumoniae Type 12f Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 18c Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 19a Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Capvaxive / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 19f Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 1 Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 1 Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 22f Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Capvaxive / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 8 Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Capvaxive / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordTeplizumab-Mzwv (Tzield)
Protein medicineApproved in the United States (FDA)Expanded recordTildrakizumab-Asmn (Ilumya)
Protein medicineApproved in the United States (FDA)Expanded recordTrastuzumab Emtansine (Kadcyla)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane, separately
Ustekinumab-Kfce (Yesintek)
Protein medicineApproved in the United States (FDA)Expanded recordVaricella-Zoster Virus Strain Oka/Merck Live Antigen (Varivax)
Protein medicineLaboratory or animal-stage researchExpanded recordVelmanase Alfa-Tycv (Lamzede)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Non-central nervous system manifestations of alpha-mannosidosis
Eculizumab-Aeeb (Bkemv)
Protein medicineApproved in the United States (FDA)Expanded recordMirvetuximab Soravtansine-Gynx (Elahere)
Protein medicineApproved in the United States (FDA)Expanded recordMumps Virus Strain B Level Jeryl Lynn Live Antigen (M-M-R II / Proquad)
Protein medicineLaboratory or animal-stage researchExpanded recordNarsoplimab-Wuug (Yartemlea)
Protein medicineApproved in the United States (FDA)Expanded recordNeisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen (Menquadfi)
Protein medicineLaboratory or animal-stage researchExpanded recordNemolizumab-Ilto (Nemluvio)
Protein medicineApproved in the United States (FDA)Expanded recordNirsevimab-Alip (Beyfortus)
Protein medicineApproved in the United States (FDA)Expanded recordOvine Digoxin Immune Fab (Digifab)
Protein medicineLaboratory or animal-stage researchExpanded recordPalifermin (Kepivance)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Kepivance is a mucocutaneous epithelial human growth factor indicated to decrease the incidence and duration of severe oral mucositis in patients with hematologic malignancies receiving myelotoxic therapy in the setting of autologous hematopoietic stem cell support. Kepivance is indicated as supportive care for preparative regimens predicted to result in ≥ WHO Grade 3 mucositis in the majority of patients.
Pectinase
Protein medicineDietary supplement; not FDA-approved as a medicineExpanded recordPegademase Bovine (Adagen)
Protein medicineApproved in the United States (FDA)Expanded recordPegfilgrastim-Apgf (Nyvepria)
Protein medicineApproved in the United States (FDA)Expanded record